Table 2: PMTCT
cascade services at selected local health centers.
Observed parameters |
Urban |
Rural |
Total |
p |
|||
Number of women at PMTCT
services |
Utilization of services
(%) |
Number of women at PMTCT services |
Utilization of services
(%) |
Number of women at PMTCT services |
Utilization of services
(%) |
||
All
women at ANC |
12,661 |
‡ |
7,271 |
‡ |
19,932 |
‡ |
|
Pregnant
women tested for HIV |
12,362 |
97.6 |
7270 |
99.9 |
19,632 |
98.5 |
0.22 |
pWLHIV |
366 |
3.0 |
203 |
2.8 |
569 |
2.9 |
0.97 |
Tuberculosis
screening among pWLHIV |
115 |
31.4 |
13 |
6.4 |
128 |
22.5 |
<
0.001 |
Active
tuberculosis among pWLHIV |
2 |
1.7 |
0 |
0.0 |
2 |
1.6 |
‡ |
Recent
past TB medical history among pWLHIV |
11 |
3.0 |
2 |
1.0 |
13 |
2.3 |
0.31 |
Prescription
of cotrimoxazole prophylaxis during pregnancy |
362 |
98.9 |
200 |
98.5 |
562 |
98.8 |
0.99 |
Prescription
of cotrimoxazole prophylaxis during postnatal
period |
235 |
64.2 |
125 |
61.6 |
360 |
63.3 |
0.76 |
Infant
cotrimoxazole prophylaxis from 6 weeks of age |
362 |
98.9 |
203 |
100.0 |
565 |
99.3 |
0.31 |
Samples
for liver & kidney function tests collected |
338 |
92.3 |
35 |
17.2 |
373 |
65.6 |
<
0.001 |
‡: not calculated;
Note: †: 4 stillbirths excluded.